scispace - formally typeset
Journal ArticleDOI

Complex Inclusion Bodies and Defective Proteome Hubs in Neurodegenerative Disease: New Clues, New Challenges.

TLDR
A brief evolutionary background of inclusion bodies (IBs) and their functional relevance for prokaryotes, plants, and animals is presented in this paper, with a very primitive knowledge of structural compositions of amyloid inclusions.
Abstract
A healthy physiological environment of cells represents the dynamic homeostasis of crowded molecules A subset of cellular proteome forms protein quality control (PQC) machinery to maintain an uninterrupted synthesis of new polypeptides and targeted elimination of old or defective proteins The process of PQC may get overwhelmed under specific genetic mutations, environmental stress conditions, and aging-associated perturbances Many of these conditions may lead to the generation of various types of aberrant protein species that may or may not accumulate as large cellular inclusions These proteinaceous formations, referred to as inclusion bodies (IBs), could be membrane-bound or membrane-less, cytoplasmic, or nuclear Most importantly, they could either be toxic or protective Under acute stress conditions, the formation of aggregates may cause proteostasis failure, leading to large-scale changes in the cellular proteome compositions However, the large insoluble IBs may act as reservoirs for many soluble proteins with high aggregation propensities, which can overwhelm the cellular chaperoning capacity and protein degradation machinery The kinetic equilibrium between folding and unfolding, misfolding, and refolding; aggregation and degradation is perturbed in one or many neurodegenerative disorders (NDDs) associated with dementia, cognitive impairments, movement, and behavioural losses However, a detailed interplay of IBs into the manifestation of the NDDs is unknown, and a very primitive knowledge of structural compositions of amyloid inclusions is present The present article presents a brief evolutionary background of IBs; their functional relevance for prokaryotes, plants, and animals; and associated involvement in neuronal proteostasis

read more

Citations
More filters
Journal ArticleDOI

Exploring the Role of Ubiquitin–Proteasome System in Parkinson's Disease

TL;DR: The current level of knowledge is outlined, focusing on important unanswered problems, and the relationship between the ubiquitin-proteasome system and neurodegeneration is strengthened.
Journal ArticleDOI

Biochemical Purification and Proteomic Characterization of Amyloid Fibril Cores from the Brain.

TL;DR: This novel, robust protocol describes the biochemical purification of amyloid plaque cores using sodium dodecyl sulfate (SDS) solubilization with sucrose density gradient ultracentrifugation and ultrasonication and yields highly pure fibrils from AD patients and AD model brain tissues.
Journal ArticleDOI

Neurodegeneration & imperfect ageing: Technological limitations and challenges?

TL;DR: A detailed overview of current state-of-the-art techniques and advances in studying amyloid in the diseased brain is provided in this article. But, these studies face multiple technological challenges in utilizing available tools for detailed characterizations of the protein aggregates or amyloids and developing new techniques to understand the biology and pathology of proteopathies.
Journal ArticleDOI

Urea induced unfolding of rai seed cystatin: Influence of glycerol as a chemical chaperone.

TL;DR: In this paper , the role of glycerol in the refolding and/or reactivation of the unfolded RSC form was investigated, and it was shown that glyceroline was a potent structural stabilizer as it assisted in the re-folding and re-activation of RSC in dosage-dependent manner.
References
More filters
Journal ArticleDOI

Neuropathological stageing of Alzheimer-related changes.

Heiko Braak, +1 more
TL;DR: The investigation showed that recognition of the six stages required qualitative evaluation of only a few key preparations, permitting the differentiation of six stages.
Journal ArticleDOI

Alzheimer's Disease: Genes, Proteins, and Therapy

TL;DR: Evidence that the presenilin proteins, mutations in which cause the most aggressive form of inherited AD, lead to altered intramembranous cleavage of the beta-amyloid precursor protein by the protease called gamma-secretase has spurred progress toward novel therapeutics and provided discrete biochemical targets for drug screening and development.
Journal ArticleDOI

Protein folding and misfolding

TL;DR: The manner in which a newly synthesized chain of amino acids transforms itself into a perfectly folded protein depends both on the intrinsic properties of the amino-acid sequence and on multiple contributing influences from the crowded cellular milieu.
Journal ArticleDOI

Protein aggregation and neurodegenerative disease.

TL;DR: There is increased understanding of the pathways involved in protein aggregation, and some recent clues have emerged as to the molecular mechanisms of cellular toxicity, leading to approaches toward rational therapeutics.
Journal ArticleDOI

Molecular chaperones in protein folding and proteostasis

TL;DR: It is suggested that an age-related decline in proteostasis capacity allows the manifestation of various protein-aggregation diseases, including Alzheimer's disease and Parkinson's disease, which may spring from a detailed understanding of the pathways underlying proteome maintenance.
Related Papers (5)